公开(公告)号：US20150045064A1

公开(公告)日：2015-02-12

申请号：US13976237

申请日：2012-12-28

Applicant: Martin Junkar ,  Jun Su ,  Minnie Ho ,  Ke Ding

Inventor： Martin Junkar ,  Jun Su ,  Minnie Ho ,  Ke Ding

IPC: H04W4/02

CPC classification number: H04W4/021 ,  G06Q10/0833 ,  H04L67/18 ,  H04M1/72572 ,  H04W4/023 ,  H04W64/00

Abstract: In one embodiment a controller comprises logic configured to receive, in the controller, a geofencing definition and input from at least one location information device, update a location of the controller using one or more location parameters from one or more location information devices, and generate a notification signal when the location of the controller indicates that the controller has crossed a threshold. Other embodiments may be described.

Abstract translation: 在一个实施例中，控制器包括被配置为在控制器中接收来自至少一个位置信息设备的地理围栏定义和输入的逻辑，其使用来自一个或多个位置信息设备的一个或多个位置参数更新控制器的位置，并且生成 当控制器的位置指示控制器已经越过阈值时的通知信号。 可以描述其他实施例。

公开(公告)号：US20130124232A1

公开(公告)日：2013-05-16

申请号：US13703471

申请日：2010-06-12

Applicant: Guoqing Zhao ,  Zhi Zhang ,  Haixing Zhou ,  Guy Cases Langhoff ,  Jesus Lopez Mijan ,  Karel Hol Soto Borja ,  Monica Reidl ,  Werner Gnan ,  Michael Seubert ,  Bin Fu ,  Rui Zhou ,  Gaogao Zheng ,  Xiaoming Wang ,  Debiao Cao ,  Ke Ding

Inventor： Guoqing Zhao ,  Zhi Zhang ,  Haixing Zhou ,  Guy Cases Langhoff ,  Jesus Lopez Mijan ,  Karel Hol Soto Borja ,  Monica Reidl ,  Werner Gnan ,  Michael Seubert ,  Bin Fu ,  Rui Zhou ,  Gaogao Zheng ,  Xiaoming Wang ,  Debiao Cao ,  Ke Ding

IPC: G06Q10/06

CPC classification number: G06Q10/067 ,  G06Q40/02

Abstract: A business object model, which reflects data that is used during a given business transaction, is utilized to generate interfaces. This business object model facilitates commercial transactions by providing consistent interfaces that are suitable for use across industries, across businesses, and across different departments within a business during a business transaction. In some operations, software creates, updates, or otherwise processes information related to Indian employee payroll input, Indian social insurance arrangement, and Indian tax arrangement business objects.

Abstract translation: 用于反映在给定业务事务期间使用的数据的业务对象模型被用于生成接口。 该业务对象模型通过提供一致的接口来促进商业交易，该接口适合于在业务交易期间跨业务，跨企业以及业务中的不同部门使用。 在某些操作中，软件创建，更新或以其他方式处理与印度员工工资单，印度社会保险安排和印度税务安排业务对象相关的信息。

公开(公告)号：US20110071148A1

公开(公告)日：2011-03-24

申请号：US12879415

申请日：2010-09-10

Applicant: Ke Ding ,  Chiwai Wong ,  Zhanfang Kang ,  Xi Zhou

Inventor： Ke Ding ,  Chiwai Wong ,  Zhanfang Kang ,  Xi Zhou

IPC: A61K31/517 ,  C07D239/91 ,  C07D401/04 ,  C07D471/04 ,  C07D413/06 ,  C07D239/90 ,  A61K31/519 ,  A61K31/5377 ,  A61P3/10 ,  A61P3/04 ,  A61P3/06 ,  A61P3/00 ,  A61P9/10

CPC classification number: C07D239/86 ,  C07D239/90 ,  C07D239/91 ,  C07D471/04 ,  C07D487/04

Abstract: The compounds according to formula VIII, their pharmaceutically acceptable acid or base addition salts, and the uses thereof is disclosed. These compounds and their pharmaceutically acceptable acid or base addition salts can be used for the preparing a medicament for modulating estrogen related receptor (ERR), and treating metabolic diseases, such as high blood fat, fatty liver, hyperglycemia, diabetes, obesity, etc. The definition of the groups of the formula is defined as the description.

Abstract translation: 公开了根据式VIII的化合物，其药学上可接受的酸或碱加成盐及其用途。 这些化合物及其药学上可接受的酸或碱加成盐可用于制备用于调节雌激素相关受体（ERR）的药物，以及治疗诸如高血脂，脂肪肝，高血糖症，糖尿病，肥胖症等代谢疾病。 公式组的定义定义为描述。

公开(公告)号：US20150005039A1

公开(公告)日：2015-01-01

申请号：US14128229

申请日：2013-06-29

Applicant: Min Liu ,  Mei Lu ,  Ke Ding

Inventor： Min Liu ,  Mei Lu ,  Ke Ding

IPC: H04M1/725 ,  H04M19/04

CPC classification number: H04M1/72569 ,  H04M19/04

Abstract: A user device including a haptic feedback system configured to receive and process data captured by one or more sensors and determine contextual characteristics of the user device and a surrounding environment based on the captured data. The contextual characteristics may include, but are not limited to, ambient noise level and ambient light level of the surrounding environment, as well as user possession, movement and/or use and interaction with the device. The haptic feedback system is further configured to adjust haptic feedback effects of the user device based, at least in part, on the contextual characteristics of the user device and surrounding environment so as to provide an optimized haptic feedback effect to the user.

Abstract translation: 一种包括触觉反馈系统的用户设备，其被配置为接收和处理由一个或多个传感器捕获的数据，并基于所捕获的数据确定所述用户设备和周围环境的上下文特征。 上下文特征可以包括但不限于周围环境的环境噪声水平和环境光水平，以及用户拥有，移动和/或与设备的使用和交互。 触觉反馈系统还被配置为至少部分地基于用户设备和周围环境的上下文特性来调整用户设备的触觉反馈效果，以便向用户提供优化的触觉反馈效果。

公开(公告)号：US08548816B1

公开(公告)日：2013-10-01

申请号：US12626161

申请日：2009-11-25

Applicant: Lijie Tang ,  Ke Ding

Inventor： Lijie Tang ,  Ke Ding

IPC: G10L19/02

CPC classification number: G10L19/035

Abstract: An efficient approach for estimating scalefactors for use in the quantization of audio signal spectrum values is described. The scalefactor estimation approach can be implemented in multiple stages. A first stage estimates a distortion level for a selected scalefactor band spectrum value based on a received maximum tolerant distortion threshold and the spectrum values in the scalefactor band. A second stage determines an interim process value based on the previously estimated distortion level and generates a scalefactor for a selected scalefactor band spectrum value based on the generated interim process value and a statistically predetermined fraction. A third stage generates a scalefactor that applies to the whole scalefactor band based on the scalefactor generated for the selected scalefactor band spectrum value. The approach provides a performance gain of 40% over previous techniques, thereby reducing device power requirements and audio encoder bottlenecks.

Abstract translation: 描述了用于估计在音频信号频谱值的量化中使用的比例因子的有效方法。 比例因子估计方法可以在多个阶段实现。 第一级基于接收的最大容限失真阈值和比例因子频带中的频谱值来估计所选择的比例因子频带频谱值的失真电平。 第二阶段基于先前估计的失真水平来确定中间过程值，并且基于所生成的中间过程值和统计预定分数来生成所选择的比例因子频谱频谱值的比例因子。 第三级基于为所选择的比例因子频带频谱值生成的比例因子产生适用于整个比例因子频带的比例因子。 该方法比以前的技术提供了40％的性能提升，从而降低了设备功率需求和音频编码器瓶颈。

公开(公告)号：US08503802B1

公开(公告)日：2013-08-06

申请号：US13427113

申请日：2012-03-22

Applicant: Ke Ding

Inventor： Ke Ding

IPC: G06K9/36 ,  H04N7/12

CPC classification number: H04N19/59 ,  H04N19/162 ,  H04N19/17 ,  H04N19/176 ,  H04N19/44 ,  H04N19/46 ,  H04N19/48 ,  H04N19/60 ,  H04N19/85

Abstract: A method of processing an image includes the steps of receiving selection of the first region of interest (ROI) of an image, processing the first image data related to the first ROI, displaying the first image ROI based on the first image data, receiving selection of the second ROI of the image, which at least partially overlapping the first ROI, processing the second image data related to a portion of the second ROI that does not overlap the first ROI, combining the processed second image data with the processed first image data that overlaps the second ROI, and displaying the second image ROI based on the combined processed second image data and the processed first data.

Abstract translation: 处理图像的方法包括以下步骤：接收图像的第一感兴趣区域（ROI）的选择，处理与第一ROI相关的第一图像数据，基于第一图像数据显示第一图像ROI，接收选择 所述图像的第二ROI与所述第一ROI至少部分重叠，处理与不与所述第一ROI重叠的所述第二ROI的一部分相关的所述第二图像数据，将所处理的第二图像数据与所处理的第一图像数据 所述第二ROI与所述第二ROI重叠，并且基于所述组合处理的第二图像数据和所处理的第一数据显示所述第二图像ROI。

公开(公告)号：US20130196985A1

公开(公告)日：2013-08-01

申请号：US13807678

申请日：2011-06-03

Applicant: Ke Ding ,  Deping Wang ,  Duanqing Pei ,  Zhang Zhang ,  Mengjie Shen ,  Kun Luo ,  Yubing Feng

Inventor： Ke Ding ,  Deping Wang ,  Duanqing Pei ,  Zhang Zhang ,  Mengjie Shen ,  Kun Luo ,  Yubing Feng

IPC: C07D487/04 ,  C07D471/04 ,  C07D401/12 ,  C07D403/12 ,  C07D401/14

CPC classification number: C07D487/04 ,  C07D239/42 ,  C07D401/12 ,  C07D401/14 ,  C07D403/12 ,  C07D471/04

Abstract: The heterocyclic alkynyl benzene compounds of formula (I), their pharmaceutically acceptable salts and stereoisomers thereof, as well as application in preparing drugs for preventing or treating tumors. The compounds can overcome the clinically induced resistance against Gleevec.

Abstract translation: 式（I）的杂环炔基苯化合物，其药学上可接受的盐和立体异构体，以及用于制备用于预防或治疗肿瘤的药物的应用。 这些化合物可以克服临床上对Gleevec的抵抗力。